TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05060666

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: 2 doses of Ivermectin will be administered with 48 hours time interval.~The dosage is based on body weight calculated as follows:~* 15 mg for 40-60 kg = 5 tablets à 3 mg~* 18 mg for 60-80 kg = 6 tablets à 3 mg~* 24 mg for \> 80 kg = 8 tablets à 3 mg each~This corresponds to an ivermectin dose of about 300 µg / kg.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: An analogous number of tablets is administered for placebo:~* 5 tablets for 40-60 kg~* 6 tablets for 60-80 kg~* 8 tablets for \> 80 kg~The size, appearance, smell and taste of the tablets of placebo are identical to Ivermectin.
Study: NCT06044831

Intervention type: BEHAVIORAL
Intervention: Expanded Population Health Model
Description: This intervention includes the current population health model in addition to expanded programming from a local community organization. The current population health model with Baylor Scott \& White Health and Wellness Center includes access to primary care, general wellness programs such as cooking classes and nutritional counseling, and evidence-based disease management and prevention. The additional programs from a local community organization focus on human essentials integral to improving health and quality of life and include: health and wellness, economic stability, safe and affordable housing, transportation, a sense of belonging, education, and access to fair credit.
Study: NCT05433012

Intervention type: DEVICE
Group type: OTHER
Intervention: Ultrahigh Field MRI at 7T
Description: Assessment of the micro-anatomy of the menisci and cartilage in patients with presumed Isolated Acute Anterior Cruciate Ligament Injury with Ultrahigh Field MRI at 7T
Study: NCT06132295

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing care
Description: 1. Consistent Schedule for the Replacement of Positioning Line Pens~2. Tailored Educational Content~3. Hypoallergenic Adhesive Patches~4. Enriched Treatment Care Platform~5. Participants with BMI \> 25 and an education level of high school or below, without specific caregivers, were identified by placing a red dot on the treatment record and on the patient's happiness card. Patients with BMI \< 25 and an education level of high school or above, with specific caregivers, were identified by placing a green dot on their records.~6. Individual interventions, educational pamphlets prepared in-house were added, to assess the maintenance status of the positioning marks.
Study: NCT05961579

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Barrier Renew
Description: RoC Skincare (New York, New York, USA) has developed a gentle cleanser and moisturizer that are free of exfoliants, astringents, and other abrasive ingredients. The moisturizer contains emollients, humectants, and silicones to improve the functioning of the skin barrier while antioxidants protect against environmental damage and inflammation
Study: NCT06213246

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Hygiene Strategies
Description: The sleep hygiene strategies will be applied for all seven days of Week 3 and will involve the following guidelines recommended by the National Sleep Foundation~* Maintain a consistent wake-up and bedtime schedule during workdays.~* Do not delay/advance excessively (no more than 2 hours) the wake-up and bedtime - schedule during weekends.~* Keep the bedroom temperature below 22°C.~* Avoid sources of light and noise in the bedroom.~* Use the bed only for sleeping, avoiding other activities before bedtime.~* Avoid daytime naps during workdays.~* Refrain from using electronic devices (PC, laptop, cellphone, television) at least 30 minutes before bedtime.~* Expose yourself to natural light in the morning and reduce artificial lights in the evening.~* Avoid consuming alcoholic beverages and caffeine in the afternoon.~* Have a moderately sized dinner at least 3 hours before bedtime.
Study: NCT05779969

Intervention type: OTHER
Intervention: Chest CT scan
Description: Comparison of structural damage to the manubriosternal joint (MST) between a population of patients with radiographic axSpA and a control population free of chronic inflammatory rheumatism on chest CT.

Intervention type: OTHER
Intervention: Chest CT scan
Description: Comparison of structural damage to the manubriosternal joint (MST) between a population of patients with radiographic axSpA and a control population free of chronic inflammatory rheumatism on chest CT.
Study: NCT05430152

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low-Dose Naltrexone
Description: Study drug dosing schedule (LDN):~* Week 1: 1 mg/day (1 mg cap)~* Week 2: 2 mg/day (two 1 mg caps)~* Week 3: 3 mg/day (three 1mg caps)~* Weeks 4-6: 4.5 mg/day (three 1 mg caps, plus one 1.5 mg cap = 4.5 mg/day)~* Weeks 7-16: 4.5 mg/day (one 4.5 mg cap) OR based on self-titration dosage (one 1mg, 2mg, or 3mg cap)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study drug dosing schedule (Placebo; capsules made to match LDN doses):~* Week 1: 1 mg/day (1 mg cap)~* Week 2: 2 mg/day (two 1 mg caps)~* Week 3: 3 mg/day (three 1mg caps)~* Weeks 4-6: 4.5 mg/day (three 1 mg caps, plus one 1.5 mg cap = 4.5 mg/day)~* Weeks 7-16: 4.5 mg/day (one 4.5 mg cap) OR based on self-titration dosage (one 1mg, 2mg, or 3mg cap)
Study: NCT06556589

Intervention type: BEHAVIORAL
Intervention: Collaborative Care
Description: Collaborative care components include patient-centered team care, population-based care, measurement-based treatment to target, evidence-based care, and accountable care.
Study: NCT04923256

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AAT-APP: A novel smart-phone approach-avoidance bias modification intervention
Description: Participants allocated to the intervention group will be required to upload photos of drinks they wish to avoid, as well as activities they wish to engage in more, and be trained to avoid and approach by repeatedly 'swiping' images away from and towards themselves, respectively.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sham training control
Description: Complete an AAT on a weekly basis for four weeks
Study: NCT06071208

Intervention type: DRUG
Intervention: Gliflozin
Description: to study whether the use of gliflozin prevented diabetic complications

Intervention type: DRUG
Intervention: Gliflozin
Description: to study whether the use of gliflozin prevented diabetic complications
Study: NCT06504498

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 0.5 mm-thick Duran® clear aligner
Description: 0.5 mm-thick clear aligner was used for orthodontic treatment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 0.75 mm-thick Duran® clear aligner
Description: 0.75 mm-thick clear aligner was used for orthodontic treatment.
Study: NCT06040333

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard therapy
Description: Patient education, massage, diaphragmatic breathing, kegel exercise
Study: NCT05966311

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous Ultrasound Gastrostomy
Description: Ultrasound guided placement of gastrostomy tube using the PUMA-G Pediatric System
Study: NCT06040333

Intervention type: OTHER
Group type: OTHER
Intervention: Standard therapy
Description: Patient education, massage, diaphragmatic breathing, kegel exercise
Study: NCT06521892

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: social surveillance and health education interventions
Description: Social surveillance: In the intervention group retail pharmacies posted or hung signs antibiotics need to be purchased by prescription, if found without prescription sales, welcome to call 12315 hotline to report, to form social supervision intervention.~Health education: On-site training for retail pharmacy staff, inviting respiratory physicians and pediatricians to give health education lectures on disease diagnosis, treatment and medication.
Study: NCT06443255

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cociane hydrochloride 4%
Description: 2 mL of 4% cocaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine 4%
Description: 1.5 mL of 4% lidocaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xylometazoline 0.1%
Description: 0.5 mL of xylometazoline 0.1%

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline 0.9%
Description: 2 mL of saline 0.9%
Study: NCT05505968

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headset
Description: Virtual Reality Headset of the society Healthy Mind and is a CE Class 1 medical device. This virtual reality headset is a Pico G2 4K and corresponds to the model A7510 and is connected to a Bose Sound Link 2 AE headset.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headset
Description: Virtual Reality Headset of the society Healthy Mind and is a CE Class 1 medical device. This virtual reality headset is a Pico G2 4K and corresponds to the model A7510 and is connected to a Bose Sound Link 2 AE headset.
Study: NCT05550376

Intervention type: OTHER
Intervention: Registry
Description: Non-interventional registry

Intervention type: OTHER
Intervention: Registry
Description: Non-interventional registry
Study: NCT05236842

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sulthiame
Description: oral

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sulthiame
Description: oral

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sulthiame
Description: oral
Study: NCT06630910

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreaticojejunostomy without stenting and omental patch
Description: A traditional pancreaticoduodenectomy with pylorus preservation was performed on each patient. A pancreaticojejunostomy was created by double-layered, end-to-side, duct-to-mucosa anastomosis between the primary pancreatic duct and jejunal wall without stenting or omental patch.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreaticojejunostomy with stenting and omental patch
Description: A traditional pancreaticoduodenectomy with pylorus preservation was performed on each patient. A pancreaticojejunostomy was created by double-layered, end-to-side, duct-to-mucosa anastomosis between the primary pancreatic duct and jejunal wall, a nelaton stent 6f was inserted into the pancreatic duct and jejunum of each patient receiving PJ. The larger omentum was separated longitudinally over an avascular zone, and one or two omental branches of the gastroepiploic arteries were preserved using pedicle omental flaps. The omental flap was pushed between the posterior surface of PJ and the portal vein, then wrapped over the anterior surface of PJ. The omentum was rolled up and secured with a few PDS sutures.
Study: NCT06086899

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)
Description: Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Korean medical treatment
Description: acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Korean medical treatment
Description: acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine
Study: NCT05236842

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sulthiame
Description: oral
Study: NCT06469762

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry Cupping
Description: Dry cupping treatment session, using 4 regular plastic cups on the lumbar spine for 10 minutes.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Dry Cupping
Description: Dry cupping treatment session, using 4 plastic cups with two 2 mm holes drilled in either side of them, on the lumbar spine for 10 minutes.
Study: NCT05907720

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Human-centered design prototype solutions for vulnerable pregnant women
Description: The intervention package will include various social and behavior change programs derived from a human-centered design approach. The intervention will be tailored to vulnerable pregnant women's needs and contexts. It may include but is not limited to health communication campaigns, including radio and print media.
Study: NCT06054269

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FLUAD Quadrivalent
Description: 0.5 mL intramuscular dose of FLUAD Quadrivalent

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FluQuadri
Description: 0.5 mL intramuscular dose of FluQuadri
Study: NCT05384132

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SRP + Livfresh Dental Gel
Description: SRP at baseline with use of LDG (test dentifrice) for twice daily brushing between study visits. Scaling and root planing is the physical removal of dental plaque, calculus, and bacterial exotoxins embedded onto the root surface of effected teeth with hand instruments and ultrasonic devices. In addition to scaling and root planing, the participants will use LDG as their primary dentrifice (toothpaste) for the next 6 months. They're instructed to use LDG twice daily with toothbrushing for 2 minutes. LDG in previous studies have been reported to be superior to conventional over-the-counter toothpaste in terms of reducing bacterial plaque and gingival inflammation due to its EDTA (ethylenediaminetetraacetic acid) ingredient. EDTA prevents adhesion of bacterial plaque to teeth.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SRP + standard flouride dentifrice
Description: SRP at baseline with use of standard fluoride dentifrice (control dentifrice) for twice daily brushing between study visits. Scaling and root planing is the physical removal of dental plaque, calculus, and bacterial exotoxins embedded onto the root surface of effected teeth with hand instruments and ultrasonic devices. In addition to scaling and root planing, the participants will use standard fluoride toothpaste (commercial over-the-counter toothpaste) as their primary dentrifice (toothpaste). They're instructed to use standard fluoride toothpaste twice daily with toothbrushing for 2 minutes.
Study: NCT05593588

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fisetin
Description: 20 mg per kilogram (kg) of body weight supplied in 100 mg capsules and administered orally on days 0, 1, 28, and 29
Study: NCT04998812

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Description: Post-partum dosing and treatment duration are at the discretion of the physicians, in accordance with local clinical practice and local labelling.
Study: NCT04964674

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Measurement
Description: Take measurements of behavioral performance
Study: NCT05451940

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Description: Hydroxyurea is an orally available antimetabolite medication that has been shown to reduce the frequency of painful crises and acute chest syndrome in adults and children with sickle cell disease. Hydroxyurea treats sickle cell disease by a number of different mechanisms, including increasing the expression of fetal hemoglobin (HbF), which reduces sickling of red blood cells.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epoetin Alfa
Description: Epoetin alfa is a first-generation erythropoiesis-stimulating agent (ESA), which are recombinant versions of erythropoietin (EPO) produced using recombinant DNA technology. Erythropoietin (EPO) is a glycoprotein hormone, naturally produced mainly in the kidneys in response to hypoxia and stimulates red blood cell production (erythropoiesis) in the bone marrow.
Study: NCT05539482

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Information Sharing Group
Description: Collaborators are encouraged to collect and share health information to the participants. Shared information should be previewed by researchers.
Study: NCT06239558

Intervention type: OTHER
Intervention: Qualitative exploration
Description: Semi-structured Interviews and focus group

Intervention type: OTHER
Intervention: Qualitative exploration
Description: Semi-structured Interviews and focus group

Intervention type: OTHER
Intervention: Qualitative exploration
Description: Semi-structured Interviews and focus group
Study: NCT06040788

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: immediate implant placement with customized healing abutment
Description: immediate implant placement with customized healing abutment
Study: NCT05288192

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Suprachoroidal triamcinolone acetonide (SCTA) injection
Description: Suprachoroidal injection of 4mg/0.1ml of triamcinolone acetonide.
Study: NCT05074914

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: oesophagectomy
Description: removal of oesophagus
Study: NCT06407713

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intrinsic foot muscle training
Description: The duration of intervention will be 6 weeks, 3 sessions a week, a total of 18 sessions will be given to the study participants. Each session will last for 30 minutes. Conventional physical therapy will be given to participants along with intrinsic foot muscle training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intrinsic foot muscle training
Description: The duration of intervention will be 6 weeks, 3 sessions a week, a total of 18 sessions will be given to the study participants. Each session will last for 30 minutes. Conventional physical therapy will be given to participants along with intrinsic foot muscle training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hip abductor muscle training
Description: The duration of intervention will be 6 weeks, 3 sessions a week, a total of 18 sessions will be given to the study participants. Each session will last for 30 minutes. Conventional physical therapy will be given to participants along with hip abductor muscle training
Study: NCT04881084

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital storytelling group
Description: Participants (intervention- group 1) will watch digital stories, short videos describing the experience of recovering from mental illness created as part of this project. Participants in the control group (group 2) will watch social marketing and/or fundraising campaigns on similar topics and complete a few questionnaires. The following standardized scales will be used: The Level of Familiarity Scale (LOF) (which will be used only before exposure to movies); Toronto Empathy Questionnaire (16 items; internal consistency coefficient .79; test-retest reliability coefficient .73), Compassionate Love Scale (21 items; Cronbach's alpha: .95; item-to-total correlations ranging from .46 to .81), Dispositional Positive Emotions Scale (DPES) (5 items; Cronbach's alpha for the compassion subscale: .80; inter-scale correlations: .44), Self-Stigma of Mental Illness Scale-Short Form (SSMIS-SF) (20 items; Cronbach's alpha: 0.91); Difference and Disdain Scales for Public Stigma (DDSPS) (9 items).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Social marketing/fundraising group
Description: Participants will be randomly assigned to the social marketing/fundraising group (n = 40 participants; 20 Anglophone and 20 Francophone; ages 18-35). Participants will be asked to watch twenty-six social marketing/fundraising videos which will be assessed using a between-subjects design.
Study: NCT05593588

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Looks exactly like the study drug, but it contains no active ingredient. Administered orally on days 0, 1, 28 and 29
Study: NCT06302816

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TUPLER exercises
Description: will be conducting tupler exercises, exercises that are designed to target core muscles in order to improve posture, regain core strength and reducing discomfort.~Each exercise will be repeated 10reps for 3 times on 3 days a week for 8 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SCOOP EXERCISES
Description: will be required to complete scoop exercises basically deals with Pilates which is deep core and hip strengthening and stability through breathing patterns with the utilization of transversus abdominis muscle majorly. In each exercise participant will be asked to hold pelvic floor muscles for 8sec, then relax the muscles and count to 10, repeat I for 10 times each day for 3 days a week for 8weeks. Basic commands about the positing, activation and engagement of core along with breathing control were given to the subjects.
Study: NCT06450743

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Lymphocyte Immunophenotyping Test
Description: Absolute enumeration of peripheral blood lymphocyte subpopulations

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Lymphocyte Immunophenotyping Test
Description: Absolute enumeration of peripheral blood lymphocyte subpopulations
Study: NCT06105918

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo rhPSMA-7.3 PET/CT and SPECT-CT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: Undergo EBRT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flotufolastat F-18
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutetium Lu 177 PSMA-10.1
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo rhPSMA-7.3 PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Photon Emission Computed Tomography
Description: Undergo SPECT-CT scan
Study: NCT06220084

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance for PD®
Description: The intervention consists of 16 60-min adapted to Greek culture DfPD® classes, which will be performed twice weekly for 8 weeks and instructed by a single researcher, who has the approval to use it for research reasons. The intervention will be delivered both live and online in separate periods for each participant.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance for PD®
Description: The intervention consists of 16 60-min adapted to Greek culture DfPD® classes, which will be performed twice weekly for 8 weeks and instructed by a single researcher, who has the approval to use it for research reasons. The intervention will be delivered both live and online in separate periods for each participant.